Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05426291
Other study ID # SadiKonuk
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 30, 2022
Est. completion date November 30, 2022

Study information

Verified date August 2022
Source Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Contact TUGBA YÜCEL, Md
Phone 05349542445
Email tugbayucel09@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Aimed to determine whether preoperative biomarkers (Mg, Hgb, CRP, ProBNP) would be helpful in the early diagnosis of CSA-AKI (cardiac surgery-related acute kidney injury) in patients undergoing open heart surgery.


Description:

An adult patient (aged ≥40 years) with ASA II-IV who was scheduled for elective open heart surgery under cardiopulmonary bypass (CPB) in our clinic between March 1, 2022 and October 30, 2022 will be prospectively included in this study. Patients included in the study will be divided into two groups. At least two of the preoperative biomarkers (Mg<0.85 mmol/L, Hgb<8.5 mmol/L, proBNP>480 pg/mL, CRP>5 mg/L) that are thought to be closely related to acute kidney injury after cardiac surgery Group I, patients who meet at least two of the preoperative biomarkers (Mg>0.85 mmol/L, Hgb>8.5 mmol/L, proBNP<480 pg/mL, CRP<5 mg/L) Group II will be included in the study.Standard monitoring such as electrocardiogram, non-invasive blood pressure and pulsoximetric saturation (SpO2), cerebral oximetry (bSO2, NIRS) will be performed in all open heart surgery patients. To prevent possible kidney damage, colloid fluids and mannitol will not be used as prime solution and replacement fluid in both groups. As in routine open heart surgery, mean arterial pressure (MAP) will be allowed to vary between 55 and 70 mmHg, the volume deficit will be replaced with erythrocyte suspension and/or crystalloid replacement in the form of 500 ml boluses, keeping the hematocrit above 25%. In case of need for a vasoactive agent, dopamine and/or adrenaline infusion is started in the standard open heart surgery procedure. After the operation, the patients are transferred to the cardiovascular surgery intensive care unit (ICU) under the effect of orotracheal intubation and conscious anesthesia. Demographic characteristics of patients (age, gender, height, weight, body mass index, diabetes mellitus, hypertension, peripheral vascular disease, smoking history, hyperlipidemia, atrial fibrillation history, left ventricular ejection fraction) European Cardiac Operative Risk Assessment System (EuroSCORE), baseline bSo2, preoperative magnesium, proBNP, CRP, hemoglobin, serum urea, creatinine value and calculated glomerular filtration rate, cystatin C value, diagnosis, surgical procedure, cardiopulmonary bypass time and cross clamp time will be recorded. Patients with high preoperative Cystatin C levels will be excluded from the study.Serum urea, creatinine concentration and GFR values will be evaluated and recorded at admission to the hospital, one day before surgery, admission to the intensive care unit, and in the mornings of the following 7 days. Cystatin C concentration will be evaluated and recorded the day before surgery, on the first postoperative day (24 hours after surgery).Heart apex, mean arterial pressure, Spo2, bSO2, hemoglobin and hematocrit concentration, lactate, hourly urine volume, diuretic requirement, replaced blood and fluid volume, vasoactive agents before induction of anesthesia {1}, directly before skin incision {2}, after sternum detachment {3}, 20 min after aortic cross clamp {4}, 40 min after aortic cross clamp {5}, 20 min after aortic cross clamp removal {6}, 20 min after CPB release {7}, and {8}eight operations will be recorded in time 60 minutes after leaving the CPB. In the postoperative period, daily total balance, diuretic requirement and vasoactive requirement will be recorded 7 days after the operation. Postoperative complications of the patients, length of stay in the intensive care unit, duration of mechanical ventilation, 28-day mortality will be recorded. The incidence of acute kidney injury will be compared between the patients in Group I and Group II according to the criteria of the Global Result of Improvement of Kidney Disease (KDIGO) criteria and postoperative cystatin C levels during the intraoperative and postoperative period.


Recruitment information / eligibility

Status Recruiting
Enrollment 88
Est. completion date November 30, 2022
Est. primary completion date October 30, 2022
Accepts healthy volunteers No
Gender All
Age group 40 Years to 85 Years
Eligibility Mininum Age : 40Years Maximum Age: 85 Years Sex: All Gender Base: No Accepts Healthy Volunteers:No Criteria: Inclusion Criteria: - Elective on-pomp coronary artery bypass Exclusion Criteria: - Emergency operation, - Off pump coronary artery bypass - Revision (repetitive) operation - Preoperative acute Renal failure - Preoperative chronic Renal failure - Preoperative decompansed heart failure - Valve replacement surgery

Study Design


Related Conditions & MeSH terms


Intervention

Other:
BIOMARKER LEVELS IS IT POSSIBLE TO PREDICT ACUTE RENAL DAMAGE IN THE PREOP PERIOD?
In open heart surgery, it will be followed whether acute kidney injury will develop by looking at the biomarkers in the preoperative period.

Locations

Country Name City State
Turkey BakirkoySadiKonuk Training and Searching Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary The requirement of continue venovenous hemodiafiltration (CVVHDF) After on pump surgery resulting AKI may require CVVHDF(pH<7.21, urine output < 0.5 ml/kg during 6 hours, potassium > 6 mEq/L) Immediately after surgery
Primary Predict acute renal failure in on-pomp conary artery bypass via preoperative biomarkers To detect acute kidney injury in the early period in open heart surgery and to take precautions up to postoperative 28th day
Secondary The requirement of hemodialysis during postoperative 28 days After discharging AKI will occur any time line of postoperative period ((pH<7.21, urine output < 0.5 ml/kg,potassium >6 mEq/l) up to postoperative 28th day
See also
  Status Clinical Trial Phase
Withdrawn NCT05710978 - Biomarkers to Assess Acute Kidney Injury Risk During Heat Strain N/A
Recruiting NCT06125184 - Effect of Vasopressin on Kidney and Cardiac Function in Septic Shock N/A
Completed NCT01824771 - Effects of Continuous Veno-venous Haemofiltration on Plasma Lactate in Critically Ill Patients
Recruiting NCT05189262 - Cardiopulmonary Bypass Induced Red Blood Cell Lysis
Completed NCT04921475 - Renal Regional Oxygen Saturation During Transcatheter Aortic Valve Implantation
Withdrawn NCT00306059 - Early Goal Directed Therapy for Acute Kidney Injury Phase 2
Recruiting NCT05555511 - Perioperative Use of NAC to Prevent AKI in Patients With Pre-existing Moderate Renal Insufficiency Following Cardiac Surgery N/A
Not yet recruiting NCT04181281 - Validation of Renal Perfusion CEUS Against MRI, and Its Application in Acute Kidney Injury
Recruiting NCT02417896 - Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery N/A